$AMIX

 $AMIX (Autonomix Medical) – Key Points

• 🏥 Development-stage medical device company listed on NASDAQ.
• 🧠 Developing catheter-based technology to detect and treat nerve-related disorders.
• 🎯 Primary focus is pain management for pancreatic cancer patients.
• ❤️ Future target markets include hypertension, cardiovascular, and chronic pain treatment.
• 🔬 Clinical-stage company with no meaningful commercial revenue yet.
• 📉 Still reporting net losses, making it a high-risk, speculative stock. 
• 📊 Very small market capitalization, which can lead to high volatility. 
• 🔄 Completed a 1-for-21 reverse stock split in June 2026 to maintain Nasdaq listing requirements. 
• 📅 Next major catalyst is the upcoming earnings report and any updates on clinical trial progress. 
• ⚠️ Best suited for traders comfortable with high-risk biotech/medical device stocks driven by news and clinical milestones rather than current earnings.